FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3139163812> ?p ?o ?g. }

• W3139163812 endingPage "434" @default.
• W3139163812 startingPage "426" @default.
• W3139163812 abstract "The anesthetic etomidate modulates synaptic <i>α</i>1<i>β</i>2/3<i>γ</i>2 GABA_A receptors via binding sites located in transmembrane <i>β</i>+/<i>α</i>− interfaces. Various approaches indicate that etomidate binds near <i>β</i>2/3M286 side chains, including recent cryogenic electron microscopy images in <i>α</i>1<i>β</i>2<i>γ</i>2L receptors under nonphysiologic conditions with ∼3.5-Å resolution. We hypothesized that substituted cysteine modification and protection experiments using variably sized <i>n</i>-alkyl-methanethiosulfonate (MTS) reagents could precisely estimate the distance between bound etomidate and <i>β</i>3M286 side chains in activated functional receptors. Using voltage-clamp electrophysiology in <i>Xenopus</i> oocytes expressing <i>α</i>1<i>β</i>3M286C<i>γ</i>2L GABA_A receptors, we measured functional changes after exposing GABA-activated receptors to <i>n</i>-alkyl-MTS reagents, from methyl-MTS to <i>n</i>-decyl-MTS. Based on previous studies using a large sulfhydryl reagent, we anticipated that cysteine modifications large enough to overlap etomidate sites would cause persistently increased GABA sensitivity and decreased etomidate modulation and that etomidate would hinder these modifications, reducing effects. Based on altered GABA or etomidate sensitivity, ethyl-MTS and larger <i>n</i>-alkyl-MTS reagents modified GABA-activated <i>α</i>1<i>β</i>3M286C<i>γ</i>2L GABA_A receptors. Receptor modification by <i>n</i>-propyl-MTS or larger reagents caused persistently increased GABA sensitivity and decreased etomidate modulation. Receptor-bound etomidate blocked <i>β</i>3M286C modification by <i>n</i>-propyl-MTS, <i>n</i>-butyl-MTS, and <i>n</i>-hexyl-MTS. In contrast, GABA sensitivity was unaltered by receptor exposure to methyl-MTS or ethyl-MTS, and ethyl-MTS modification uniquely increased etomidate modulation. These results reveal a “cut-on” between ethyl-MTS and <i>n</i>-propyl-MTS, from which we infer that -<i>S</i>-(<i>n</i>-propyl) is the smallest <i>β</i>3M286C appendage that overlaps with etomidate sites. Molecular models of the native methionine and -<i>S</i>-ethyl and -<i>S</i>-(<i>n</i>-propyl) modified cysteines suggest that etomidate is located between 1.7 and 3.0 Å from the <i>β</i>3M286 side chain. <h3>SIGNIFICANCE STATEMENT</h3> Precise spatial relationships between drugs and their receptor sites are essential for mechanistic understanding and drug development. This study combined electrophysiology, a cysteine substitution, and <i>n</i>-alkyl-methanethiosulfonate modifiers, creating a precise molecular ruler to estimate the distance between a α1β3γ2L GABA type A receptor residue and etomidate bound in the transmembrane <i>β</i>+/<i>α</i>− interface." @default.
• W3139163812 created "2021-03-29" @default.
• W3139163812 creator A5019779854 @default.
• W3139163812 creator A5050184660 @default.
• W3139163812 creator A5066688284 @default.
• W3139163812 creator A5067438950 @default.
• W3139163812 date "2021-03-25" @default.
• W3139163812 modified "2023-09-27" @default.
• W3139163812 title "Substituted Cysteine Modification and Protection with n-Alkyl- Methanethiosulfonate Reagents Yields a Precise Estimate of the Distance between Etomidate and a Residue in Activated GABA Type A Receptors" @default.
• W3139163812 cites W115055041 @default.
• W3139163812 cites W1497034990 @default.
• W3139163812 cites W1592442520 @default.
• W3139163812 cites W1840025613 @default.
• W3139163812 cites W1983756509 @default.
• W3139163812 cites W1994090837 @default.
• W3139163812 cites W2045542952 @default.
• W3139163812 cites W2060685853 @default.
• W3139163812 cites W2063157730 @default.
• W3139163812 cites W2068375642 @default.
• W3139163812 cites W2069566746 @default.
• W3139163812 cites W2120869341 @default.
• W3139163812 cites W2136037216 @default.
• W3139163812 cites W2145980353 @default.
• W3139163812 cites W2161329715 @default.
• W3139163812 cites W2170087378 @default.
• W3139163812 cites W2203294517 @default.
• W3139163812 cites W2224811953 @default.
• W3139163812 cites W2377439879 @default.
• W3139163812 cites W2529294814 @default.
• W3139163812 cites W2770750894 @default.
• W3139163812 cites W2884201985 @default.
• W3139163812 cites W2906072858 @default.
• W3139163812 cites W2915027227 @default.
• W3139163812 cites W2947596811 @default.
• W3139163812 cites W2965225396 @default.
• W3139163812 cites W3082691473 @default.
• W3139163812 doi "https://doi.org/10.1124/molpharm.120.000224" @default.
• W3139163812 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33766924" @default.
• W3139163812 hasPublicationYear "2021" @default.
• W3139163812 type Work @default.
• W3139163812 sameAs 3139163812 @default.
• W3139163812 citedByCount "0" @default.
• W3139163812 crossrefType "journal-article" @default.
• W3139163812 hasAuthorship W3139163812A5019779854 @default.
• W3139163812 hasAuthorship W3139163812A5050184660 @default.
• W3139163812 hasAuthorship W3139163812A5066688284 @default.
• W3139163812 hasAuthorship W3139163812A5067438950 @default.
• W3139163812 hasBestOaLocation W31391638121 @default.
• W3139163812 hasConcept C12554922 @default.
• W3139163812 hasConcept C166342909 @default.
• W3139163812 hasConcept C168258287 @default.
• W3139163812 hasConcept C170493617 @default.
• W3139163812 hasConcept C178790620 @default.
• W3139163812 hasConcept C181199279 @default.
• W3139163812 hasConcept C185592680 @default.
• W3139163812 hasConcept C19876734 @default.
• W3139163812 hasConcept C2776277131 @default.
• W3139163812 hasConcept C2779201268 @default.
• W3139163812 hasConcept C2779570518 @default.
• W3139163812 hasConcept C2779676917 @default.
• W3139163812 hasConcept C2780263894 @default.
• W3139163812 hasConcept C40875361 @default.
• W3139163812 hasConcept C55493867 @default.
• W3139163812 hasConcept C71240020 @default.
• W3139163812 hasConcept C80161118 @default.
• W3139163812 hasConcept C86803240 @default.
• W3139163812 hasConcept C98274493 @default.
• W3139163812 hasConceptScore W3139163812C12554922 @default.
• W3139163812 hasConceptScore W3139163812C166342909 @default.
• W3139163812 hasConceptScore W3139163812C168258287 @default.
• W3139163812 hasConceptScore W3139163812C170493617 @default.
• W3139163812 hasConceptScore W3139163812C178790620 @default.
• W3139163812 hasConceptScore W3139163812C181199279 @default.
• W3139163812 hasConceptScore W3139163812C185592680 @default.
• W3139163812 hasConceptScore W3139163812C19876734 @default.
• W3139163812 hasConceptScore W3139163812C2776277131 @default.
• W3139163812 hasConceptScore W3139163812C2779201268 @default.
• W3139163812 hasConceptScore W3139163812C2779570518 @default.
• W3139163812 hasConceptScore W3139163812C2779676917 @default.
• W3139163812 hasConceptScore W3139163812C2780263894 @default.
• W3139163812 hasConceptScore W3139163812C40875361 @default.
• W3139163812 hasConceptScore W3139163812C55493867 @default.
• W3139163812 hasConceptScore W3139163812C71240020 @default.
• W3139163812 hasConceptScore W3139163812C80161118 @default.
• W3139163812 hasConceptScore W3139163812C86803240 @default.
• W3139163812 hasConceptScore W3139163812C98274493 @default.
• W3139163812 hasIssue "6" @default.
• W3139163812 hasLocation W31391638121 @default.
• W3139163812 hasLocation W31391638122 @default.
• W3139163812 hasLocation W31391638123 @default.
• W3139163812 hasOpenAccess W3139163812 @default.
• W3139163812 hasPrimaryLocation W31391638121 @default.
• W3139163812 hasRelatedWork W1835484750 @default.
• W3139163812 hasRelatedWork W2017824404 @default.
• W3139163812 hasRelatedWork W2018188393 @default.
• W3139163812 hasRelatedWork W2095259008 @default.
• W3139163812 hasRelatedWork W2114509523 @default.
• W3139163812 hasRelatedWork W2161329715 @default.

• next